Search
Research
A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12-24 MonthsRespiratory syncytial virus (RSV) causes serious illness in children. The Ad26.RSV.preF vaccine candidate was immunogenic with acceptable safety in a phase 1/2a study of RSV-seropositive children. Here, we assessed its safety and immunogenicity in RSV-seronegative children.
Learn more about the Wesfarmers Centre of Vaccines and Infectious Diseases
To improve the health of the community through immunisation and prevention of infectious diseases, we are conducting clinical trials of vaccines.

The CHIP Study investigates how burn injuries in children affect their immune system.
Allergies have been on the rise in Australia over the past 20 years, with three out of every 10 babies born each year now developing a food-related
Contact us If you'd like to get in touch, please contact us by phone or email. Phone: 0400 450 240 Email: vtg@thekids.org.au The Vaccine Trials Group
CMVictory: finding a vaccine for cytomegalovirus, a serious virus for unborn babies
Māori and Pacific Governance groups were formed before the initiation of the study. They have continued to meet periodically to discuss and inform

News & Events
Hep C can be cured, but many people are still not being treatedPeople living with hepatitis C in WA are being urged to take part in a new project, aimed at encouraging the take-up of treatment.
Thank you to our Sponsors Contact us If you'd like to get in touch, please contact Marie Nadal-Sims by phone or email. Phone: (08) 6319 1001 Email: